Evidence map›Paper›PMID 27965674›Full record

ReviewFrontiers in immunology2016

Molecular and Cellular Characterization of Human CD8 T Suppressor Cells.

Zheng Xu, Sophey Ho, Chih-Chao Chang, Qing-Yin Zhang, Elena-Rodica Vasilescu, George Vlad, Nicole Suciu-Foca

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. LILRB4, from the immune system to the disease target.American journal of translational research · 2020
    Review
  6. T and B Cells in Periodontal Disease: New Functions in A Complex Scenario.International journal of molecular sciences · 2019
    Review
  7. Article
  8. CD8Inflammation · 2018
    Article
  9. Recent advances in CD8Oncology letters · 2018
    Review
  10. Review
  11. Human CD8Frontiers in immunology · 2018
    Article
  12. Article
  13. Article
  14. CD8Frontiers in immunology · 2017
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zheng XuImmunogenetics and Cellular Immunology, Department of Pathology and Cell Biology, Columbia University , New York, NY , USA.
Sophey HoImmunogenetics and Cellular Immunology, Department of Pathology and Cell Biology, Columbia University , New York, NY , USA.
Chih-Chao ChangImmunogenetics and Cellular Immunology, Department of Pathology and Cell Biology, Columbia University , New York, NY , USA.
Qing-Yin ZhangImmunogenetics and Cellular Immunology, Department of Pathology and Cell Biology, Columbia University , New York, NY , USA.
Elena-Rodica VasilescuImmunogenetics and Cellular Immunology, Department of Pathology and Cell Biology, Columbia University , New York, NY , USA.
George VladImmunogenetics and Cellular Immunology, Department of Pathology and Cell Biology, Columbia University , New York, NY , USA.
Nicole Suciu-FocaImmunogenetics and Cellular Immunology, Department of Pathology and Cell Biology, Columbia University , New York, NY , USA.
Columbia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bidirectional interactions between dendritic cells and Ag-experienced T cells initiate either a tolerogenic or immunogenic pathway. The outcome of these interactions is of crucial importance in malignancy, transplantation, and autoimmune diseases. Blockade of costimulation results in the induction of T helper cell anergy and subsequent differentiation of antigen-specific CD8

Indexed as

autoimmune diseaseCD8+ T suppressor cellsco-stimulation blockadegene profile of CD8+ TsILT3transplantation

Identifiers

PMID27965674
PMCPMC5127796
OpenAlexW2559495611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.